Pharmacodynamics, safety, and immunogenicity of Pelmeg？, a pegfilgrastim biosimilar in healthy subjects

DOI: 10.1002/prp2.507

Keywords: biosimilars, filgrastim, highly similar, myelosuppressive chemotherapy, neutropenia, oncology, pegfilgrastim, supportive care

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text